Loading…

Swiss medtech company Ypsomed has begun construction of a new production plant in Schwerin, Germany, investing over EUR 100 million to produce injection and infusion systems, creating about 150 jobs. The plant is expected to be ready for occupancy in January 2019 with production starting in Q2 2019.
“Mit dem von IE Plast 'von innen nach außen geplanten' neuen Werk sollen zukünftig hocheffizient Injektions- und Infusionssysteme produziert und rund 150 neue Arbeitsplätze geschaffen werden.”k-zeitung.de
Summarized from public sources; check the original articles before acting on it.